Protecting the patents of expensive medicines for longer would affect low-income countries. Jason Reed/ReutersPics

Time for costly medicine monopolies to go from TPP trade talks

Negotiators from 11 countries have been racing to resurrect the near-dead Trans-Pacific Partnership Agreement before the Asia-Pacific Economic Cooperation (APEC) summit this weekend.
Pfizer’s evergreening tactics have made it the target of protests. Michael Fleshman/Flickr

Explainer: evergreening and how big pharma keeps drug prices high

Efforts by pharmaceutical companies to extend their patents cost taxpayers millions of dollars each year. In some cases they also mean people are subjected to unnecessary clinical trials. Big pharma makes…
Patents have exploded in number in recent years, thanks largely to our lax standards for issuing them. www.shutterstock.com

How trade agreements are locking in a broken patent system

Ten years on from the Australia-US Free Trade Agreement, Australia is entering another round of negotiations towards the new and controversial Trans-Pacific Partnership. In this Free Trade Scorecard series…

Contact Hazel for

  • General
  • Media request
  • Speaking request
  • Consulting / Advising
  • Research collaboration
  • Research supervision